David T. Rubin, MD
Disclosures: Consulting Fee-AbbVie|Consulting Fee-Altrubio|Stocks or stock options, excluding diversified mutual funds-Altrubio|Consulting Fee-Allergan|Consulting Fee-Arena Pharmaceuticals|Consulting Fee-Aslan Pharmaceuticals|Consulting Fee-Athos Therapeutics|Consulting Fee-Bellatrix Pharmaceuticals|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Celgene|Consulting Fee-Connect BioPharma|Consulting Fee-GalenPharma/Atlantica|Consulting Fee-Genentech, Inc.|Consulting Fee-Glycominds|Consulting Fee-InDex Pharmaceuticals|Consulting Fee-Ironwood Pharmaceuticals|Consulting Fee-Iterative Scopes|Consulting Fee-Janssen|Consulting Fee-Lilly USA|Consulting Fee-Materia Prima|Consulting Fee-Pfizer, Inc.|Consulting Fee-Prometheus Biosciences|Consulting Fee-Reistone |Consulting Fee-Takeda|Grant or research support-Takeda|Consulting Fee-Techlab, Inc - 10/15/2021
No Bio Available.